[Federal Register Volume 85, Number 163 (Friday, August 21, 2020)]
[Notices]
[Page 51850]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-18410]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Genomic Medicine Program Advisory Committee

    The Department of Veterans Affairs (VA) gives notice under the 
Federal Advisory Committee Act, that a meeting of the Genomic Medicine 
Program Advisory Committee (the Committee) will be held virtually on 
Tuesday, September 29, 2020. The meeting will begin at 11 a.m. EDT and 
adjourn at 3 p.m. EDT. The meeting is open to the public via Webex 
https://veteransaffairs.webex.com/webappng/sites/veteransaffairs/meeting/download/2fe78c5a7b874c6398af6379146b75bc?siteurl=veteransaffairs&MTID=mc2d13b50a0af24cf5a588b56eb6ad82d password 2NSxcpaP@33 or by phone at call in +1 
(404) 397-1596 meeting code: 1993331445#.
    The purpose of the Committee is to provide advice and make 
recommendations to the Secretary of Veterans Affairs on using genetic 
information to optimize medical care for Veterans and to enhance 
development of tests and treatments for diseases particularly relevant 
to Veterans.
    On September 29, 2020, the Committee will receive updated briefings 
on various VA research programs, including the Million Veteran Program 
(MVP) to ascertain the progress of the program in the areas of 
participant recruitment, data generation and storage, and data access. 
The Committee will also receive updates from ongoing MVP research, 
including new COVID related research, return of genetics results pilot 
studies, draft recommendations from a subcommittee on Genomics Services 
within the VA, and a new initiative on increasing diversity and 
inclusion in VA research. Additionally, the Committee will discuss and 
explore potential recommendations to be included in the next annual 
report.
    Public comments will be received at 2:15 p.m. EDT and are limited 
to 5 minutes each. Individuals who speak are invited to submit a 1-2 
page summary of their comments for inclusion in the official meeting 
record to Jennifer Moser, Designated Federal Officer, Office of 
Research and Development (10X2), 810 Vermont Avenue NW, Washington, DC 
20420, or at [email protected]. In the communication, writers must 
identify themselves and state the organization, association or 
person(s) they represent. Any member of the public who wishes to attend 
the teleconference should RSVP to Jennifer Moser at 202-510-4253 no 
later than close of business, September 22, 2020, at the phone number 
or email address noted above.

    Dated: August 18, 2020.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2020-18410 Filed 8-20-20; 8:45 am]
BILLING CODE P